SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a memecoin on the Bitcoin network, is trending as the community rallies around its potential as the first fair-launched meme on Bitcoin L2 with big names and whales watching. Discussions revolve around its strong community, decentralized nature, and the possibility of reaching $1, with some highlighting its role in driving demand for Bitcoin blockspace. The 'DOG Army' is actively promoting the token, emphasizing its unique position within the Bitcoin ecosystem.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation of a potential licensing deal with AstraZeneca and positive sentiment surrounding its cancer drug, ivonescimab. The community is actively discussing the possibility of a significant upfront payment and the potential for the drug to challenge existing treatments. Anticipation is building as investors await further news and data releases, with some highlighting the stock's high short interest as a catalyst for a potential squeeze.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as community members rally around its potential to become the leading memecoin on the Bitcoin network, with some suggesting it could surpass Dogecoin. Key talking points include its fair launch, decentralized nature, and strong community backing. Many believe it's poised for significant growth and exchange listings.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as a potential Real World Asset (RWA) coin, drawing comparisons to $XRP.X and $XLM.X. The community highlights its low market cap and potential for integration with the XRP ledger, viewing it as an early opportunity. Community members are actively discussing where to buy the coin and sharing enthusiasm for its potential gains.

Sapien is an open protocol for sourcing verified human knowledge at scale. Its network of millions of contributors spans more than 100 countries, ranging from doctors and engineers to artists and students. Together they produce high-quality AI training data, validated through Sapien’s onchain Proof of Quality system. This ensures enterprises and AI developers can access trusted, human-in-the-loop data while transforming fragmented online work into a sustainable, reputation-based profession. Incentives across the network are powered by the $SAPIEN token, an ERC-20 asset on Base.

Sapien

Sapien.X is trending as the community discusses its potential for significant gains, with some drawing comparisons to other recently successful tokens. The token's chart setup and appealing levels are generating interest, while others speculate about potential scams. The recent listing and overall market conditions abroad are also being mentioned as potential catalysts.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending as traders discuss its low float and potential for a significant price surge, reminiscent of other recent low float runners. Community members are highlighting the stock's scarce shares and growing watcher count, suggesting a possible squeeze. Some are pointing to a recent land sale that could boost NAV.

Numeraire

Numeraire is trending as traders discuss a recent investment from a major US bank into the AI-based crypto hedge fund, which some believe could lead to significant growth. The community is actively analyzing price charts, identifying potential breakout points, and anticipating further upward momentum. With a relatively low circulating supply, many are speculating on substantial long-term gains.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

BBBY is trending as the ticker reactivates, sparking confusion and discussion among traders about Overstock's acquisition of the Bed Bath & Beyond brand and its implications for previous shareholders. The community is actively debating the company's future, potential partnerships, and the possibility of a short squeeze, drawing comparisons to the $GME saga. Some investors express skepticism, citing past financial difficulties, while others see potential in the company's blockchain initiatives.

Tidal Trust III - Fundstrat Granny Shots US Large Cap ETF

Fundstrat Granny Shots US Large Cap ETF

The Fundstrat Granny Shots US Large Cap ETF ($GRNY) is trending as investors discuss its holdings and recent performance, with many referencing Tom Lee's bullish outlook and stock-picking strategy. Community members are weighing the ETF's expense ratio against its potential for long-term growth and diversification, with some speculating about future inclusion of specific assets. The ETF is gaining traction as a way to invest in multiple key investment themes and is being compared to benchmark indexes.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Resmed Inc.

ResMed ($RMD) is trending amid speculation about a potential buyout or partnership with Incannex ($IXHL), driven by positive clinical trial data for a sleep apnea pill that could disrupt the CPAP market. The community is closely watching for an announcement, especially given that a ResMed executive is on Incannex's advisory board, with some speculating this is a strategic move before Phase 3 trials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abercrombie & Fitch Company (ANF) Is a Trending Stock: Facts to Know Before Betting on It

Abercrombie (ANF) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

International Markets and Abercrombie (ANF): A Deep Dive for Investors

Evaluate Abercrombie's (ANF) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Abercrombie &amp; Fitch (ANF) CFO Robert Ball said on Wednesday that the assumed impact from the Trump administration’s tariffs carries a cost impact of around $90 million for 2025, impacting the company’s full-year operating margin outlook by 170 basis points.The company had initially anticipated $50 million impact from tariffs. “We continue to expect China sourcing share of the U. S. will be in the low single digits for the year and we have minimal exposure to the de minimis exemption that is no longer in place,” Ball said during a post-earnings call.He added that the company has diversified sourcing across 16 countries and the team is continuing to evaluate supply chain footprint changes, vendor negotiations, and operating expense efficiencies that “will largely take shape in fiscal 2026.”Retail sentiment on <a href="https://stocktwits.com/symbol/ANF">Abercrombie &amp; Fitch</a> improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with chatter at ‘extremely high’ levels, according to data from Stocktwits.<figure class="image"><img style="aspect-ratio:808/102;" src="https://news.stocktwits-cdn.com/ANF_sentiment_png_35b3aa6423.webp" alt="ANF sentiment.png" width="808" height="102"><figcaption>ANF sentiment and message volume August 27, 2025, as of 1:25 pm ET | Source: Stocktwits</figcaption></figure>The company raised its fiscal 2025 net sales forecast to be between 5% and 7% increase, up from the previous estimate of 3% to 6%. Abercrombie now expects annual profit per share between $10.00 and $10.50, compared to the prior forecast of $9.50 to $10.50.Ball added that the company will work to pull back promotional days “here and there” to see consumer response and will watch how it plays out for the back&nbsp;half of the year.Abercrombie’s second-quarter net sales came in at $1.21 billion, compared with Wall Street expectations of $1.19 billion, according to data compiled by Fiscal AI. Its quarterly adjusted earnings per share (EPS)&nbsp;were $2.32, topping estimates of $2.27.Shares of Abercrombie were down over 35% so far this year and have declined nearly 30% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/j-m-smucker-warns-of-volume-hit-as-coffee-prices-rise-retail-mood-sours/chsUe7TRdlJ">J.M. Smucker Warns Of Volume Hit As Coffee Prices Rise, Retail Mood Sours</a>&nbsp;

Sign at the entrance to the Abercrombie & Fitch store in Midtown Manhattan.

Abercrombie CFO Flags $90M Tariff Blow, Retail Still Bets Big

Abercrombie raised its fiscal 2025 net sales forecast to be between 5% and 7% increase, up from the previous estimate of 3% to 6%.

Equity

Abercrombie Q2 Earnings Top Estimates, Hollister Brand Up 19%

ANF tops Q2 estimates with record results, fueled by Hollister's 19% gain, and raises its full-year outlook.

Markets Await PCE Data

Countdown to NVIDIA Earnings, PCE Report Friday

No major economic prints this Hump Day will keep the laser-focus most market participants currently: NVIDIA earnings.

Abercrombie (ANF) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Abercrombie (ANF) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Abercrombie & Fitch (ANF) Q2 Earnings and Revenues Surpass Estimates

Abercrombie (ANF) delivered earnings and revenue surprises of +2.20% and +1.55%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

U.S. stocks appear set for a positive opening on Wednesday as investors brace for&nbsp;earnings reports from AI bellwether Nvidia Corp. (NVDA) and a few retailers.The market heavyweight’s earnings, due after the closing bell, and CEO Jensen Huang’s comments will be keenly watched across industries.In the broader market,&nbsp;Dow Jones futures were up 0.03% at the time of writing, the S&amp;P 500 futures rose 0.4%, and the tech-heavy Nasdaq 100’s futures were up 0.05%. Futures of the Russell 2000 index were down 0.1%.Meanwhile, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) was up 0.07% at the time of writing, while&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) edged 0.08% higher on Wednesday morning. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bullish’ territory.Among Asian markets, the Shanghai Composite index declined the most on Wednesday, falling 1.76%. The Hang Seng index&nbsp;dropped 1.27%,&nbsp;while&nbsp;the KOSPI closed 0.25% higher, and&nbsp;the&nbsp;Nikkei 225&nbsp;gained&nbsp;0.30%.&nbsp;The TWSE Capitalization Weighted Stock index closed the day up by 0.8%.Stocks To Watch<ul><li>MongoDB Inc.(MDB) surged 30%&nbsp;in pre-market trade after it reported quarterly earnings of $1 per share, which beat the analyst estimate of $0.66, as per Fiscal AI data. Quarterly revenue came in at $591.4 million, beating the Street estimate of $553.57 million.</li><li>&nbsp;</li><li>PVH Corp.(PVH) rose over 7%&nbsp;after it reported earnings of $2.52 per share, which beat the analyst estimate of $2.00. Quarterly revenue of $2.17 billion beat the $2.11 billion estimate.</li><li>&nbsp;</li><li>Okta Inc. (OKTA) advanced over 5% after reporting second-quarter revenue of $728 million, beating analyst estimates of $711.8 million. Its adjusted earnings of $0.91 per share beat analyst estimates of $0.85 per share.</li></ul>Apart from Nvidia, other notable names reporting on Wednesday include Abercrombie &amp; Fitch (ANF), Donaldson (DCI), J.M. Smucker, Inc. (SJM), Kohl’s (KSS), Williams-Sonoma (WSM), Bill.com (BILL), CrowdStrike (CRWD).&nbsp;

Traders work on the floor of the New York Stock Exchange (NYSE) on August 22, 2025, in New York City. 

Dow Futures Edge Higher As Investors Await Nvidia Earnings: MDB, PVH, OKTA, ANF, KSS, CRWD Among Stocks To Watch

As momentum builds around Nvidia’s AI dominance and demand, the market heavyweight’s earnings and CEO Jensen Huang’s comments will be keenly watched across industries.

MRVL's Q2 Earnings Likely to be Powered by AI Silicon & Data Center Boom

Marvell Technology's second-quarter earnings are likely to be driven by surging demand for custom AI silicon, electro-optics and data center.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

ANF
Abercrombie & Fitch Co.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANF News

ANF Abercrombie & Fitch Co.